Member Database

Sofia Merajver

GreaterGood Breast Cancer Research Professor
Internal Medicine - Hematology/Oncology
Medicine

MS, Physics, University of Maryland
PhD, Physics (Minor: Biophysics), University of Maryland
MD, University of Michigan

Sofia Merajver is Professor of Internal Medicine and Epidemiology at U-M. The author of 280 peer-reviewed publications, Merajver, an expert in breast cancer genetics and precision medicine, is Director of the Breast and Ovarian Cancer Risk Evaluation Program and the Scientific Director of the Breast Oncology group at the Rogel Cancer Center. Her research interests include precision medicine to treat every patient with the right drug, the molecular basis of aggressive  cancers, and the discovery of new drugs based on the science.


Projects:

Biomarkers of drug response, Predictive biomarkers of brain metastasis, Tumor heterogeneity and evolution

University Affiliation(s)

Rogel Cancer Center

Community and Professional Affiliation(s)

AACR | ACCA | American Society of Clinical Oncology | MDHHS

Research Area(s)

Biomarkers | Computational Biology | Genetics / Genomics / other OMICS | Health disparities

Grants

  • Principal investigator of: PILOT STUDY OF DESLORELIN, ESTRADIOL & TESTOSTERONE IN WOMEN AT HIGH RISK OF BREAST CANCER TO REDUCE BREAST DENSITY TO ENHANCE MAMMOGRAPHIC SCREENING.
  • Principal investigator of: PROTOCOL P-2: A STUDY OF TAMOXIFEN AND RALOXIFENE FOR THE PREVENTION OF BREAST CANCER
  • Co-investigator of: Phase II Trial of Tetrathiomolybdate in Prostate Cancer